🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationPeptide degradation products — what worked for you? Page 2

Peptide degradation products — what worked for you?

mona_PHX Fri, Aug 30, 2024 at 3:56 AM 13 replies 1,843 viewsPage 2 of 3
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
Aug 30, 2024 at 6:46 AM#6
Both Frank and Rick make excellent points and they're not mutually exclusive. The standard panel (HPLC + ESI-MS) is: - Sufficient for verifying identity and basic quality ✓ - Insufficient for full pharmaceutical characterization ✓ - The best available option for community-level testing given cost constraints ✓ - Not a substitute for proper pharmaceutical manufacturing controls ✓ My advice for the average person here: get the standard panel and use it to make informed decisions. If the mass spec confirms identity and HPLC shows >97% purity and correct content, you've eliminated the most common quality issues (wrong product, low purity, underfilling). If you want to go further, the community-funded testing initiative (see the other thread) is exploring more advanced testing like SEC for aggregation. Pooling resources makes the expensive tests accessible. For now, ESI-MS identity confirmation remains the single most important test you can get. It's the only way to conclusively prove that what's in the vial is what it claims to be. HPLC tells you purity and potency — critical information, but useless if the product isn't actually semaglutide.
Last edited: Aug 30, 2024 at 8:46 AM
13 8SleepDoc_PDX, RegAffairsDC, BiostatsBrad and 10 others
Reply Quote Save Share Report
LondonLisa
Member
912
3,456
Mar 2024
London, UK
Aug 30, 2024 at 7:03 AM#7
This entire thread is going into my notes. I'm a biochem undergrad and I've learned more about practical analytical chemistry from these forum discussions than from my coursework. Quick question: on the ESI-MS spectrum for semaglutide, which charge state typically gives the strongest signal? I've been looking at some published spectra and the +4 and +5 charge states seem dominant, but I'm not sure if that's always the case.
5 11Dr.MetabolicMD, RetaRick_CA, JenPlateau and 2 others
Reply Quote Save Share Report
NeuroNate
Senior Member
2,890
16,789
Dec 2023
Chicago, IL
Aug 30, 2024 at 7:20 AM#8
For semaglutide, the +4 and +5 charge states typically dominate — you're right. The exact charge state distribution depends on: - Solvent conditions (more acidic → higher charge states) - Cone voltage / source temperature settings - The protein/peptide's surface charge distribution For a ~4100 Da peptide with several basic residues (arginines and lysines), the +4 charge state (m/z ~1029) is usually the base peak (most intense). The +5 (m/z ~824) and +3 (m/z ~1372) are typically 40-70% relative intensity. Software deconvolution combines all charge states to give you the molecular weight. The beauty of ESI is that the multiply charged envelope itself is a kind of fingerprint — the spacing between peaks tells you the charge states, and from those you calculate the mass. It's mathematically elegant and practically reliable. Glad you're learning from these discussions. Analytical chemistry in the real world is way more interesting than textbook problems. If you want to go deeper, look up the "MaxEnt" deconvolution algorithm — it's what most software uses to go from raw ESI spectra to molecular weight, and it's a fascinating application of information theory to chemistry.
Last edited: Aug 30, 2024 at 1:20 PM
17 5sarah_TO, wendy_avl, jason_paloalto and 14 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register